RXDX insider filings

Prometheus Biosciences, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-16. Screen RXDX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for RXDX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Prometheus Biosciences, Inc.

FiledFormInsiderReported transactionsSource
2023-06-164Hendrix Martin — DirectorDisposition to issuer (D): 2,071 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 20,500 (derivative)EDGAR
2023-06-164Stenhouse Mark — Chief Operating OfficerDisposition to issuer (D): 12,754 · Disposition to issuer (D): 14,000 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 240,000 (derivative) · Disposition to issuer (D): 70,371 (derivative) · Disposition to issuer (D): 86,582 (derivative) · +1 moreEDGAR
2023-06-164McKenna Mark C. — Chairman, President and CEO, DirectorDisposition to issuer (D): 178,098 · Disposition to issuer (D): 161,105 (derivative) · Disposition to issuer (D): 132,741 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 481,725 (derivative) · Disposition to issuer (D): 566,307 (derivative) · +3 moreEDGAR
2023-06-164Laur James — DirectorDisposition to issuer (D): 2,071 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 20,500 (derivative)EDGAR
2023-06-164Marshall Keith W — Chief Financial OfficerDisposition to issuer (D): 87,973 · Disposition to issuer (D): 52,838 (derivative) · Disposition to issuer (D): 93,040 (derivative) · Disposition to issuer (D): 135,913 (derivative) · Disposition to issuer (D): 102,155 (derivative) · Disposition to issuer (D): 86,582 (derivative) · +2 moreEDGAR
2023-06-164Adams Helen C. — DirectorDisposition to issuer (D): 2,674 · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 1,083 (derivative) · Disposition to issuer (D): 21,526 (derivative)EDGAR
2023-06-164Swain Judith L — DirectorDisposition to issuer (D): 2,071 · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 20,500 (derivative)EDGAR
2023-06-164Szela Mary T — DirectorDisposition to issuer (D): 2,071 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 20,500 (derivative)EDGAR
2023-06-164PAPA JOSEPH C — DirectorDisposition to issuer (D): 7,278 · Disposition to issuer (D): 10,000 · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 27,340 (derivative) · Disposition to issuer (D): 22,652 (derivative) · Disposition to issuer (D): 2,165 (derivative) · +1 moreEDGAR
2023-06-164Hassan Fred — DirectorDisposition to issuer (D): 2,123 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 541 (derivative) · Disposition to issuer (D): 21,013 (derivative)EDGAR
2023-06-024McKenna Mark C. — Chairman, President & CEO, DirectorOption exercise (M): 122,528 @ $2.90 · Option exercise (M): 3 @ $1.70 · Option exercise (M): 122,528 (derivative) @ $0 · Option exercise (M): 3 (derivative) @ $0EDGAR
2023-06-024Stenhouse Mark — Chief Operating OfficerOther (J): 14,000 @ $0 · Other (J): 14,000 @ $0EDGAR
2023-06-024Marshall Keith W — Chief Financial OfficerOption exercise (M): 78,162 @ $3.10 · Option exercise (M): 78,162 (derivative) @ $0EDGAR
2023-06-024PAPA JOSEPH C — DirectorOther (J): 10,000 @ $0 · Other (J): 10,000 @ $0EDGAR
2023-05-194Laur James — DirectorGrant/award (A): 2,071 @ $0EDGAR
2023-05-194Hendrix Martin — DirectorGrant/award (A): 2,071 @ $0EDGAR
2023-05-194Adams Helen C. — DirectorGrant/award (A): 2,174 @ $0EDGAR
2023-05-194Swain Judith L — DirectorGrant/award (A): 2,071 @ $0EDGAR
2023-05-194Szela Mary T — DirectorGrant/award (A): 2,071 @ $0EDGAR
2023-05-194PAPA JOSEPH C — DirectorGrant/award (A): 2,278 @ $0EDGAR
2023-05-194Hassan Fred — DirectorGrant/award (A): 2,123 @ $0EDGAR
2023-04-074Marshall Keith W — Chief Financial OfficerOption exercise (M): 10,000 @ $3.70 · Sale (S): 10,000 @ $108.42 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-03-174McKenna Mark C. — Chairman, President & CEO, DirectorOption exercise (M): 25,000 @ $2.90 · Sale (S): 25,000 @ $116.14 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2023-03-084Cedars Sinai Intellectual Property Co — 10% ownerSale (S): 865,000 @ $114.59EDGAR
2023-03-084Marshall Keith W — Chief Financial OfficerOption exercise (M): 10,000 @ $3.70 · Sale (S): 10,000 @ $122.13 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-03-034McKenna Mark C. — Chairman, President & CEO, DirectorOption exercise (M): 700 @ $3.70 · Sale (S): 700 @ $125.26 · Option exercise (M): 10,620 @ $3.70 · Sale (S): 10,620 @ $125.13 · Option exercise (M): 700 (derivative) @ $0 · Option exercise (M): 10,620 (derivative) @ $0EDGAR
2023-02-174McKenna Mark C. — Chairman, President & CEO, DirectorOption exercise (M): 25,000 @ $2.90 · Sale (S): 25,000 @ $119.42 · Option exercise (M): 25,000 @ $3.70 · Sale (S): 25,000 @ $119.87 · Option exercise (M): 13,680 @ $3.70 · Sale (S): 13,680 @ $125.10 · +3 moreEDGAR
2023-02-174Marshall Keith W — Chief Financial OfficerOption exercise (M): 5,000 @ $3.70 · Sale (S): 5,000 @ $119.38 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-01-194McKenna Mark C. — Chairman, President & CEO, DirectorOption exercise (M): 25,000 @ $2.90 · Sale (S): 25,000 @ $118.99 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2023-01-194Marshall Keith W — Chief Financial OfficerOption exercise (M): 5,000 @ $3.70 · Sale (S): 5,000 @ $119 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2022-12-204Marshall Keith W — Chief Financial OfficerGrant/award (A): 12,920 (derivative) @ $0EDGAR
2022-12-134Stenhouse Mark — Chief Operating OfficerGrant/award (A): 9,811 @ $0 · Grant/award (A): 34,085 (derivative) @ $0EDGAR
2022-12-134McKenna Mark C. — Chairman, President & CEO, DirectorGrant/award (A): 37,113 @ $0 · Grant/award (A): 128,930 (derivative) @ $0EDGAR
2022-12-134Marshall Keith W — Chief Financial OfficerGrant/award (A): 9,811 @ $0 · Grant/award (A): 34,085 (derivative) @ $0EDGAR
2022-05-204Laur James — DirectorGrant/award (A): 20,500 (derivative) @ $0EDGAR
2022-05-204Hendrix Martin — DirectorGrant/award (A): 20,500 (derivative) @ $0EDGAR
2022-05-204Stenhouse Mark — Chief Operating OfficerGrant/award (A): 86,582 (derivative) @ $0EDGAR
2022-05-204McKenna Mark C. — Chairman, President & CEO, DirectorGrant/award (A): 246,639 (derivative) @ $0EDGAR
2022-05-204Marshall Keith W — Chief Financial OfficerGrant/award (A): 86,582 (derivative) @ $0EDGAR
2022-05-204Adams Helen C. — DirectorGrant/award (A): 21,526 (derivative) @ $0EDGAR
2022-05-204Swain Judith L — DirectorGrant/award (A): 20,500 (derivative) @ $0EDGAR
2022-05-204Szela Mary T — DirectorGrant/award (A): 20,500 (derivative) @ $0EDGAR
2022-05-204PAPA JOSEPH C — DirectorGrant/award (A): 22,551 (derivative) @ $0EDGAR
2022-05-204Hassan Fred — DirectorGrant/award (A): 21,013 (derivative) @ $0EDGAR
2022-04-054Cedars Sinai Intellectual Property Co — 10% ownerOther (J): 142,376 @ $0EDGAR
2021-12-034McKenna Mark C. — Chairman, President & CEO, DirectorOption exercise (M): 15,400 @ $2.90 · Option exercise (M): 15,400 (derivative) @ $0EDGAR
2021-11-164Andrews Timothy K. — General CounselGrant/award (A): 54,132 (derivative) @ $0EDGAR
2021-11-164Adams Helen C. — DirectorGrant/award (A): 1,083 (derivative) @ $0EDGAR
2021-11-164PAPA JOSEPH C — DirectorGrant/award (A): 2,165 (derivative) @ $0EDGAR
2021-11-164Hassan Fred — DirectorGrant/award (A): 541 (derivative) @ $0EDGAR

Recent 8-K events — Prometheus Biosciences, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-06-168-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-158-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2023-05-238-K8.01 — Other EventsEDGAR
2023-05-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-04-178-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-108-K7.01 — Regulation FD DisclosureEDGAR
2023-02-288-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-098-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-12-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RXDX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs